(SOF) Sofina Société Anonyme - Ratings and Ratios
Equity Stakes, Global Funds, Consumer Brands, Digital Platforms, Healthcare
Description: SOF Sofina Société Anonyme
Sofina Société Anonyme is a private equity and venture capital firm that specializes in direct and fund of funds investments, focusing on companies undergoing digital transformation, consumer & retail, education, healthcare, and other sectors. The firm invests in a diverse range of companies, including privately owned and listed companies, with a particular emphasis on European-based companies with global exposure, as well as companies in Western Europe, Asia, and the United States.
The firms investment strategy involves providing growth capital, early-stage funding, and LBO investments, with a typical investment range of €20 million to €100 million in fast-growing businesses and €100 million to €300 million in minority investments. Sofina also invests in venture and growth capital funds, with a focus on private equity, venture capital, and growth equity funds, particularly in emerging markets.
From a financial perspective, Sofinas market capitalization stands at approximately €9.16 billion, with a price-to-earnings ratio of 6.90 and a return on equity of 13.17%. To further evaluate the companys performance, we can examine additional key performance indicators (KPIs) such as dividend yield, which is around 1.45% based on the current stock price. The companys ability to generate cash flow is also crucial, with a cash flow return on investment (CFROI) that can be calculated using the available financial data.
To assess Sofinas investment portfolio, we can look at the companys historical investment performance, including the returns generated by its direct investments and fund of funds investments. Additionally, we can examine the sectoral diversification of the portfolio, including the proportion of investments in digital transformation, healthcare, and other sectors. By analyzing these KPIs, we can gain a deeper understanding of Sofinas investment strategy and its potential for future growth.
SOF Stock Overview
| Market Cap in USD | 10,926m |
| Sub-Industry | Multi-Sector Holdings |
| IPO / Inception |
SOF Stock Ratings
| Growth Rating | 22.1% |
| Fundamental | 57.8% |
| Dividend Rating | 48.8% |
| Return 12m vs S&P 500 | 2.39% |
| Analyst Rating | - |
SOF Dividends
| Dividend Yield 12m | 1.40% |
| Yield on Cost 5y | 1.49% |
| Annual Growth 5y | 2.93% |
| Payout Consistency | 91.1% |
| Payout Ratio | 14.7% |
SOF Growth Ratios
| Growth Correlation 3m | 42.9% |
| Growth Correlation 12m | 66.7% |
| Growth Correlation 5y | -32.7% |
| CAGR 5y | 1.86% |
| CAGR/Max DD 5y | 0.03 |
| Sharpe Ratio 12m | 0.68 |
| Alpha | 5.27 |
| Beta | 0.953 |
| Volatility | 27.69% |
| Current Volume | 16.2k |
| Average Volume 20d | 16.2k |
| Stop Loss | 250.8 (-3%) |
| Signal | -1.50 |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (1.26b TTM) > 0 and > 6% of Revenue (6% = 92.9m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 2.97pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 54.29% (prev -111.1%; Δ 165.4pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 665.8m <= Net Income 1.26b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 304.9 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (33.9m) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 99.51% (prev 100.9%; Δ -1.41pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 14.75% (prev -12.81%; Δ 27.56pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 51.84 (EBITDA TTM -5.14m / Interest Expense TTM 8.85m) >= 6 (WARN >= 3) |
Altman Z'' 3.75
| (A) 0.08 = (Total Current Assets 843.8m - Total Current Liabilities 2.77m) / Total Assets 11.16b |
| (B) 0.88 = Retained Earnings (Balance) 9.79b / Total Assets 11.16b |
| warn (B) unusual magnitude: 0.88 — check mapping/units |
| (C) 0.04 = EBIT TTM 458.5m / Avg Total Assets 10.50b |
| (D) 0.09 = Book Value of Equity 79.7m / Total Liabilities 853.8m |
| Total Rating: 3.75 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.81
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield 6.74% = 3.37 |
| 3. FCF Margin 42.94% = 7.50 |
| 4. Debt/Equity 0.08 = 2.50 |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC -4.31% = -5.39 |
| 7. RoE 13.17% = 1.10 |
| 8. Rev. Trend 12.95% = 0.65 |
| 9. Rev. CAGR -36.68% = -2.50 |
| 10. EPS Trend 3.83% = 0.10 |
| 11. EPS CAGR 118.6% = 2.50 |
What is the price of SOF shares?
Over the past week, the price has changed by -2.93%, over one month by -4.93%, over three months by +2.62% and over the past year by +19.76%.
Is Sofina Société Anonyme a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SOF is around 248.47 EUR . This means that SOF is currently overvalued and has a potential downside of -3.92%.
Is SOF a buy, sell or hold?
What are the forecasts/targets for the SOF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 308 | 19.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 277.7 | 7.4% |
SOF Fundamental Data Overview
Market Cap EUR = 9.38b (9.38b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 357.4m EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 6.68
P/S = 6.5503
P/B = 0.8601
Beta = 1.251
Revenue TTM = 1.55b EUR
EBIT TTM = 458.5m EUR
EBITDA TTM = -5.14m EUR
Long Term Debt = 851.0m EUR (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 2.77m EUR (from totalCurrentLiabilities, last quarter)
Debt = 853.8m EUR (Calculated: Short Term 2.77m + Long Term 851.0m)
Net Debt = 480.5m EUR (from netDebt column, last quarter)
Enterprise Value = 9.88b EUR (9.38b + Debt 853.8m - CCE 357.4m)
Interest Coverage Ratio = 51.84 (Ebit TTM 458.5m / Interest Expense TTM 8.85m)
FCF Yield = 6.74% (FCF TTM 665.2m / Enterprise Value 9.88b)
FCF Margin = 42.94% (FCF TTM 665.2m / Revenue TTM 1.55b)
Net Margin = 81.03% (Net Income TTM 1.26b / Revenue TTM 1.55b)
Gross Margin = 99.51% ((Revenue TTM 1.55b - Cost of Revenue TTM 7.64m) / Revenue TTM)
Tobins Q-Ratio = 123.9 (set to none) (Enterprise Value 9.88b / Book Value Of Equity 79.7m)
Interest Expense / Debt = 0.46% (Interest Expense 3.93m / Debt 853.8m)
Taxrate = 0.00% (from yearly Income Tax Expense: 7000 / 1.36b)
NOPAT = 458.5m (EBIT 458.5m * (1 - 0.00%))
Current Ratio = 304.9 (Total Current Assets 843.8m / Total Current Liabilities 2.77m)
Debt / Equity = 0.08 (Debt 853.8m / last Quarter total Stockholder Equity 10.31b)
Debt / EBITDA = -166.1 (Net Debt 480.5m / EBITDA -5.14m)
Debt / EBITDA = -166.1 --> set to None
Debt / FCF = 1.28 (Debt 853.8m / FCF TTM 665.2m)
Total Stockholder Equity = 9.53b (last 4 quarters mean)
RoA = 11.25% (Net Income 1.26b, Total Assets 11.16b )
RoE = 13.17% (Net Income TTM 1.26b / Total Stockholder Equity 9.53b)
RoCE = 4.42% (Ebit 458.5m / (Equity 9.53b + L.T.Debt 851.0m))
RoIC = 4.46% (NOPAT 458.5m / Invested Capital 10.28b)
WACC = 8.77% (E(9.38b)/V(10.23b) * Re(9.53%)) + (D(853.8m)/V(10.23b) * Rd(0.46%) * (1-Tc(0.00)))
Shares Correlation 5-Years: -40.0 | Cagr: -0.51%
Discount Rate = 9.53% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 76.75% ; FCFE base≈516.7m ; Y1≈637.1m ; Y5≈1.09b
Fair Price DCF = 427.2 (DCF Value 14.15b / Shares Outstanding 33.1m; 5y FCF grow 24.92% → 3.0% )
Revenue Correlation: 12.95 | Revenue CAGR: -36.68%
Rev Growth-of-Growth: 594.8
EPS Correlation: 3.83 | EPS CAGR: 118.6%
EPS Growth-of-Growth: 334.3